Author:
Marshall Eleanor M.,Koopmans Marion,Rockx Barry
Abstract
AbstractWest Nile virus (WNV) leads to thousands of cases of severe neurological disease in humans each year. Usutu virus (USUV) is closely related to WNV, but rarely induces disease in humans. We hypothesised that USUV is less able to cross the blood-brain barrier (BBB) and, consequently, is less likely to infect the brain. Therefore, we developed an in vitro BBB model consisting of primary human brain microvascular endothelial cells, pericytes and astrocytes. Both USUV and WNV invaded across the in vitro BBB via a transcellular mechanism in the absence of barrier disruption. USUV replicated to lower titres than WNV but induced a comparable cytokine and chemokine response, with modulation of key factors associated with barrier function and immune-cell migration. In conclusion, USUV appears attenuated in its ability to replicate at this interface compared with WNV, but further work must be done to identify key determinants underlying the differing clinical presentations.
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Historic Data (1999–2022) | West Nile Virus | CDC. https://www.cdc.gov/westnile/statsmaps/historic-data.html.
2. Historical data by year—West Nile virus seasonal surveillance. https://www.ecdc.europa.eu/en/west-nile-fever/surveillance-and-disease-data/historical.
3. Angeloni, G. et al. Epidemiology, surveillance and diagnosis of Usutu virus infection in the EU/EEA, 2012 to 2021. Euro Surveill. 28, 2200929 (2023).
4. Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R. & Begley, D. J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 37, 13–25 (2010).
5. Attwell, D. et al. Glial and neuronal control of brain blood flow. Nature 468, 232–243 (2010).